For citations:
Krysanov I.S., Makarova E.V., Krysanova V.S., Ermakova V.Yu., Kurkin D.V., Kolosov Yu.A. Mosunetuzumab budget impact analysis in patients with recurrent or refractory follicular lymphoma. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2025;(2):34-45. (In Russ.) https://doi.org/10.37489/2588-0519-2025-2-34-45. EDN: FNOVMB